BLAINJECTIONINJECTABLE
Approved
Sep 1994
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HUMEGON is a menotropin injection containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH), used primarily in assisted reproductive technology and fertility treatment. It stimulates ovarian follicle development and gonadal function in patients with infertility. The drug is indicated for controlled ovarian hyperstimulation in women undergoing in vitro fertilization and related reproductive procedures.
LOE Approaching
As an older biologic with LOE approaching, the brand team likely operates lean with focus on retention and competitive positioning against newer fertility therapies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
HUMEGON offers limited career upside as a legacy biologic in the late lifecycle stage with minimal linked job openings. Roles are primarily defensive and focused on maintaining market share and managing the transition to generic or biosimilar competition rather than innovation or growth.
Brand ManagerMedical Science Liaison
Worked on HUMEGON at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.